H5N8 flu vaccine study for healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests an experimental flu vaccine designed to protect against the H5N8 bird flu virus. It is given with an ingredient that may boost the immune response. The study will check if the vaccine is safe and how well it triggers the body's defenses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in good general health, with no serious ongoing medical conditions.
- If you are pregnant or breastfeeding, you cannot join. Otherwise, you must use effective birth control for the study duration.
- You cannot have a weakened immune system or be on treatments that affect immunity (like steroids for more than 2 weeks in the last 3 months).
- You must not have had a flu vaccine within the past 4 weeks before the first study dose, and you must avoid other vaccines until after day 43 of the study.
- You cannot have previously received any H5 flu vaccine (like H5N1 or H5N8).
- You must not have certain neurological conditions (like Guillain-Barré syndrome) or a history of allergic reactions to vaccine components.
- You must not have bleeding disorders or be taking blood thinners that could affect a needle injection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.